HIRO and OncoRay Lecture Series: Radiopharmaceuticals – in times of (Radionuclide) Theranostics (Prof. Dr. Klaus Kopka)

Radiolabelled  compounds  got  a  key  role  in  elucidation  of  metabolic  pathways  already  in  the 
early 50th of the last century. To date there is an ongoing application of such methods for the 
characterization of biochemical functional behavior of cells and tissues by techniques of nuclear 
medicine and for the exploitation of similar methods for therapeutic purposes. This lecture will 
give  an  insight  to  the  radiochemical  and  radiopharmacological  background  and  will  discuss 
current problems and applications. 

You can find all information on the HIRO and OncoRay Lecture Series Website.